Biodexa Pharmaceuticals Plc (BDRX)
1.245
-0.08
(-5.68%)
USD |
NASDAQ |
May 02, 16:00
1.23
-0.02
(-1.20%)
Pre-Market: 09:28
Biodexa Pharmaceuticals Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| December 31, 2020 | 0.0159 |
| June 30, 2020 | 0.7022 |
| December 31, 2019 | 0.2524 |
| June 30, 2019 | 0.0442 |
| Date | Value |
|---|---|
| December 31, 2018 | 0.0592 |
| June 30, 2018 | 0.2858 |
| December 31, 2017 | 0.1868 |
| June 30, 2017 | 0.0482 |
| December 31, 2016 | 0.0454 |
| June 30, 2016 | 0.0442 |
| December 31, 2015 | 0.0386 |
| June 30, 2015 | 0.0456 |
| December 31, 2014 | 0.0463 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2021
0.7022
Maximum
Jun 2020
0.1015
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| Adaptimmune Therapeutics PLC | 0.00 |
| NuCana PLC | -- |
| Autolus Therapeutics PLC | -- |
| Mereo BioPharma Group PLC | 0.0869 |
| Bicycle Therapeutics PLC | 0.0828 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 13.43M |
| Total Liabilities (Quarterly) | 7.470M |
| Shareholders Equity (Quarterly) | 5.959M |
| Current Ratio | 1.262 |